|
 |
Has your child or anyone you know taken Risperdal®?
Risperdal® is also known by the generic name
risperidone. If so, the child might be at risk for
serious, potentially irreversible side effects, including:
Breast development in boys (gynecomastia):
Risperdal® may increase the amount of a certain hormone (prolactin) in blood.
Symptoms may include growth of breast(s), possibly with pain or nipple discharge. A mastectomy may be required to remove the breast(s).
Involuntary muscle movements (extrapyramidal symptoms/ tardive dyskinesia):
The chance that this will happen or that it will become permanent is increased in those who take Risperdal® in higher doses or for a long time. Muscle problems may also occur after short-term treatment with low doses. There may be muscle problems in any or all of the following: arms, legs, tongue, face, mouth, or jaw. Some of the specific uncontrollable movements in the face may include tongue sticking out, puffing of cheeks, mouth puckering, and chewing movements.
Neuroleptic Malignant Syndrome (NMS):
A possibly fatal syndrome, with symptoms including stiff muscles, sweating, fever, confusion, abnormal thinking, and fast or irregular heartbeat has been reported with Risperdal® usage.
Diabetes:
There are reports of diabetes that may be linked to use of Risperdal®. Side effects of the drug, including weight gain and increase in blood sugar, may contribute to new onset diabetes.
An antipsychotic drug, Risperdal® was originally approved for use in adults with schizophrenia and, later, for treatment of acute mania or mixed episodes associated with Bipolar Disorder. However, Risperdal has consistently been prescribed for children to treat autism, irritability, aggression and other behavior disorders including Attention Deficit Disorder/Hyperactivity Disorder (ADHD). Recently, Risperdal was approved for very limited uses in children. Some children have experienced significant, dangerous side effects, such as weight gain, diabetes mellitus, movement disorders and growth of breasts in boys.
If your child has experienced any of these side effects, contact us now to learn your rights and protect the health of your child.
|
|
|
Attorney Steve Sheller and his clients
on the drug Risperdal
CBS Evening News, May 25, 2009
Risperdal stories have recently appeared:
|
|
|
|
The firm of Sheller, P.C. is nationally recognized as committed to the aggressive and compassionate representation of its clients. Sheller, P.C. maintains a practice concentrating in areas of drug product and medical device liability, medical malpractice, toxic tort and complex catastrophic personal injury litigation, consumer fraud, labor union representation and work place safety, equality and compensation.
Attorneys from Sheller, P.C. have successfully litigated groundbreaking cases dealing with everything from pharmaceutical products, medical devices, tobacco company fraud and consumer electronics fraud to racial discrimination and birth defects. Their successes have garnered press coverage from the CBS Evening News, Fox News (National), CNN, MSNBC, Good Morning America, The New York Times, Wall Street Journal, Washington Post, Los Angeles Times and Philadelphia Inquirer, among many others.
Contact us now for a free consultation to discuss your options—time is of the essence.
|
|
Attorney Disclaimers: By using this website, you agree to the
following: the information provided on this website is not intended as a substitute for medical or legal advice. With any medical condition,
issue, or concern, you should contact your doctor, pharmacist, or other health care provider. In the event of an emergency, dial 911 immediately
for emergency services. The information on this website does not create an attorney-client relationship between Sheller, P.C. or any attorney
and the user. Information from this website is not intended to substitute a medical consultation with a physician and/or direct consultation
with an attorney and you should not take or refrain from taking any action based on the information contained herein.
click here to read full disclaimer
|
 |
|
|
